Screening for heart disease: C-reactive protein versus coronary artery calcium

Amish A Patel1, Matthew J Budoff

  • 1Division of Cardiology, Los Angeles Biomedical Research Institute at Harbor-UCLA, 1124 W. Carson Street, RB2, Torrance, CA 90502, USA.

Insights

Coronary artery calcification (CAC) shows greater promise than C-reactive protein (CRP) for predicting coronary heart disease (CHD) risk. CAC improves risk prediction models, while CRP data remains inconsistent for CHD assessment.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Biomarker Research

Background:

  • The Framingham model is standard for coronary artery disease (CAD) risk assessment.
  • Nontraditional risk factors like C-reactive protein (CRP) and coronary artery calcification (CAC) are explored to enhance CAD prediction.
  • CRP is a biomarker of inflammation with inconsistent data for predicting coronary heart disease (CHD).

Purpose of the Study:

  • To evaluate the predictive value of CRP and CAC for coronary heart disease (CHD) risk.
  • To compare the effectiveness of CAC and CRP in improving existing risk stratification algorithms.
  • To determine the clinical relevance of CAC versus CRP in predicting future cardiac events.

Main Methods:

  • Review of existing literature comparing CRP and CAC in predicting cardiovascular events.
  • Analysis of studies evaluating the improvement in the C-statistic and patient reclassification when adding CRP or CAC to the Framingham risk score.
  • Examination of cohorts that assessed both CAC and CRP for future cardiovascular events.

Main Results:

  • CAC consistently improves the C-statistic and patient reclassification in risk models for coronary heart disease (CHD).
  • CRP data for CHD prediction is inconsistent, with modest reclassification (<10%) and no improvement in the C-statistic.
  • Studies comparing both CAC and CRP in the same cohort show significant predictive ability for CAC, but not for CRP.

Conclusions:

  • Coronary artery calcification (CAC) is more clinically relevant than CRP for evaluating coronary heart disease (CHD) risk.
  • CAC demonstrates a stronger relationship with future cardiac events and improves risk prediction models.
  • Further cost-effectiveness studies are needed for CAC due to its higher cost compared to CRP.

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...